The Enterprise Value as of December 2025 (TTM) for Cohance Lifesciences Limited (COHANCE.NS) is 210.27B

According to Cohance Lifesciences Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 210.27B. This represents a change of -28.11% compared to the average of 292.48B of the last 4 quarters.

Cohance Lifesciences Limited (COHANCE.NS) Historical Enterprise Value (quarterly & annually)

How has COHANCE.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of Cohance Lifesciences Limited over the last ten years is 132.16B. The current 210.27B Enterprise Value has changed 15.81% with respect to the historical average. Over the past ten years (40 quarters), COHANCE.NS's Enterprise Value was at its highest in in the September 2025 quarter at 339.35B. The Enterprise Value was at its lowest in in the December 2018 quarter at 0.

Cohance Lifesciences Limited (COHANCE.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cohance Lifesciences Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cohance Lifesciences Limited (COHANCE.NS) Average Enterprise Value

How has COHANCE.NS Enterprise Value performed in the past?

The current Enterprise Value of Cohance Lifesciences Limited (COHANCE.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cohance Lifesciences Limited (COHANCE.NS) Enterprise Value vs. Peers

How is COHANCE.NS’s Enterprise Value compared to its peers?

Cohance Lifesciences Limited’s Enterprise Value is less than Cohance Lifesciences Limited (414.34B), less than J. B. Chemicals & Pharmaceuticals Limited (285.98B), less than J. B. Chemicals & Pharmaceuticals Limited (285.98B), less than Piramal Enterprises Limited (254.86B), less than Ajanta Pharma Limited (331.25B), less than Ajanta Pharma Limited (331.25B), less than Piramal Pharma Limited (281.43B), less than Ipca Laboratories Limited (377.26B), less than Eris Lifesciences Limited (236.17B), less than AstraZeneca Pharma India Limited (227.02B),

Build a custom stock screener for Cohance Lifesciences Limited (COHANCE.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cohance Lifesciences Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cohance Lifesciences Limited (COHANCE.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cohance Lifesciences Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.